Recent CMAX Stock Price | CMAX Stock Predictions | |
$4.82 | +50.41% |
$7.25 |
Recent CMAX Analyst Ratings Breakdown, Making CMAX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 0 | 0 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 3.0 | 3.0 | 2.5 | 2.5 |
For the CMAX stock predictions from the analysts covering CareMax Inc, we have collected all of the individual CMAX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering CMAX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CMAX stock predictions may vary widely, another useful metric to consider is the median CMAX stock prediction, which represents the price at which half of the analysts
made CMAX stock predictions that were higher and half made CMAX stock predictions that were lower. This makes for a different take on the CMAX stock predictions out there, as compared to average or mean.
And that median across all the individual CMAX stock predictions was: $7.25 as of 2024-03-29.
The very highest of the CMAX stock predictions for one year price target was $7.5, while the very lowest of the CMAX stock predictions in the analyst group was
$7.0 (with a standard deviation of $0.353). Get the latest Zacks research report on CMAX — FREE
Find out: CMAX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
LOAN Stock Predictions
ES Stock Predictions
MAIN Stock Predictions
BKI Stock Predictions
HL Stock Predictions
HLX Stock Predictions
VIVO Stock Predictions
CMC Stock Predictions
EXPO Stock Predictions
|
|
Hold (2.00 out of 4) 1st percentile
(ranked lower than approx. 99% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |